Depression Clinical Trial
Official title:
Evaluating the Feasibility of Limbix Spark: a Cognitive Behavioral Therapy Based Mobile and Virtual Reality Intervention for Adolescent Depression
Depression, the most common mental health disorder among adolescents, is a critical health problem within the US. In this study, the feasibility, acceptability, and preliminary efficacy of Limbix Spark, a cognitive behavioral therapy (CBT)- based mobile app + virtual reality (VR) program for helping adolescents live well with depression will be investigated. This program is specifically designed around behavioral activation theory, the idea that completing activities that make a patient feel pleasure or provide a sense of mastery are effective in reducing symptoms of depression. The program involves the use of both VR and a mobile app that include CBT components like psychological assessments, psychoeducation, and skills training. 30 participants aged 12-21 years old with mild to severe depressive symptoms and smartphone access will be enrolled in this study. The primary efficacy outcome measures will be depressive symptoms with anxiety symptoms, functional outcomes, and dimensional scales of positive and negative affect and behavioral activation serving as secondary outcome measures. Qualitative and quantitative feedback on the use of the VR + mobile app (ease of use, comfort, willingness to use again) will be assessed using questionnaires. Engagement and adherence to the program will be assessed by assessing VR and app usage.
Depression, the most common mental health disorder among adolescents, is a major public
health concern with significant personal, societal, and economic burdens, particularly as
incidence rates are increasing. Effective care for adolescent depression is limited due to
lack of access to care, increasingly long waitlists, stigma surrounding mental health, and
ineffectiveness of pharmaceutical options. There is an urgent need for accessible,
cost-effective, and evidence-based treatment options for adolescents with depression.
The development of effective digital health programs for adolescents is a key strategy to
reduce the personal, familiar and societal burden of depression. Such programs provide an
innovative way to deliver resources in a cost-effective, accessible fashion.
Cognitive-behavioral therapy (CBT) is effective in the prevention and treatment of depression
in children and adolescents. Digital forms of CBT have also been shown to be efficacious in
the treatment of anxiety and depressive symptoms in youth, however. adherence to such
programs in clinical trials and particularly in real world evidence evaluations is low.
Virtual reality (VR) holds promise as a way to enhance adherence to and the efficacy of
digital CBT for depression.
To address the need for effective, accessible, and engaging treatments for adolescent
depression, the objective of this project is to evaluate the feasibility, acceptability, and
preliminary evidence of efficacy of Limbix Spark: a 5 week CBT-based mobile + VR self-guided
program. Limbix Spark is specifically designed to implement behavioral activation, a CBT
skill, which involves completing self-monitored activities that provide a sense of pleasure
or mastery in order to reduce depressive symptoms and improve functional outcomes. VR allows
adolescents to complete such activities in virtual environments as a potential stepping stone
to engaging in similar experiences in the real world.
30 participants aged 12-21 years old with mild to severe depressive symptoms and with smart
phone access will be enrolled. During a baseline visit, participants or participants' legal
guardians, will be asked to provide written informed consent and potential participants under
18 will be asked to provide written assent after study procedures are explained and any
questions are answered by study staff in accordance with good clinical practice (GCP) and
human subjects research guidelines.
After consent, all eligible participants will be assigned to complete the 5-week Limbix Spark
program. Participants and their legal guardian if under 18 will first complete baseline
assessments, including the Patient Health Questionnaire (PHQ-8) Generalized Anxiety Disorder
scale (GAD-7), the Positive and Negative Affective Schedule (PANAS-C), the Behavioral
Activation for Depression Scale-Short Form (BADS-SF), 20-item Short Form Survey (SF-20), Mood
and Feelings Questionnaire Short Parent version (MFQ-PS). Participants will then receive VR
equipment, and receive an initial orientation to the Limbix Spark program. Program
orientation will include training on how to set up and use the VR headset and how to download
and use the mobile app.
The 5 modules in the Limbix Spark program are meant to be completed weekly, however,
participants will be allowed to progress through the program at their own pace. Each module
contains VR and mobile app components and is expected to take no more than 60 minutes to
complete, with no more than approximately 25 min per module of VR content. Modules do not
need to be completed in a single session and can be completed over the course of several
days. During the program, weekly PHQ-8 assessments will be completed within the mobile app.
At the post-intervention site visit, participants and their legal guardian if under 18 will
complete post-program assessments, including the PHQ-8, GAD-7, PANAS-C, MFQ-PS, SF-20, and
BADS-SF, as well as a questionnaire about their thoughts and experiences with the Spark
program. Participants will also complete a qualitative interview to further understand their
experience with the program.
One month after the post-intervention site visit, participants will be sent a 1-month follow
up questionnaires via email, including the PHQ-8, GAD-7, PANAS-C, MFQ-PS, SF-20, and BADS-SF,
as well as a questionnaire about their thoughts and experiences with the Spark program.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A |